Hamid R. Mirzaei
Analiz Rodriguez
Jennifer Shepphird
Christine E. Brown
Behnam Badie2*
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
- 1Department of Medical Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
- 2Division of Neurosurgery, Department of Surgery, City of Hope National Medical Center, Duarte, CA, United States
- 3Department of Hematology and Hematopoietic Cell Transplantation, T Cell Therapeutics Research Laboratory, City of Hope Beckman Research Institute, Duarte, CA, United States
A Corrigendum on
Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications
by Mirzaei, H. R., Rodriguez, A., Shepphird, J., Brown, C. E., and Badie, B. (2017). Front. Immunol. 8:1850. doi: 10.3389/fimmu.2017.01850
In the original article, there was an error. We neglected to disclose a conflict of interest.
A correction has been made to the Conflict of Interest statement:
“Patents associated with CAR design, T cell manufacturing, and delivery have been licensed by Mustang Bio., Inc., for which CB and BB receive licensing and consulting payments.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: immunotherapy, T cell therapy, chimeric antigen receptor, CAR, solid tumors
Citation: Mirzaei HR, Rodriguez A, Shepphird J, Brown CE and Badie B (2019) Corrigendum: Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications. Front. Immunol. 10:780. doi: 10.3389/fimmu.2019.00780
Received: 11 March 2019; Accepted: 25 March 2019;
Published: 17 April 2019.
Edited and reviewed by: Katy Rezvani, University of Texas MD Anderson Cancer Center, United States
Copyright © 2019 Mirzaei, Rodriguez, Shepphird, Brown and Badie. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Behnam Badie, YmJhZGllQGNvaC5vcmc=